Saratov JOURNAL of Medical and Scientific Research

Application of rhythmic transcranial therapy with low-intensive magnetic field in the complex treatment of climacteric and postovarectomy syndromes

Year: 2021, volume 17 Issue: №3 Pages: 428-433
Heading: Obstetrics and Gynecology Article type: Original article
Authors: Neyfeld I.V., Bobyleva I.V., Rogozhina I.E.
Organization: LLC «MMK "SOVA"», Saratov State Medical University

Objective is to assess the effectiveness of the inclusion of rhythmic transcranial stimulation (rTMS) in the treatment of climacteric (CS) and postovarectomy syndromes (POES). Material and Methods. 95 women with POES (main group IA(n=48), comparison IB (n=47)) and 135 women with CS (main IIA(n=68), comparison IIB (n=67)) were included. All patients underwent menopausal hormone therapy (MHT), in the main groups — in combination with rTMS. Results. The average age of patients with POES is 47.9±2.2, with CS — 53.6±3.5 years (p=0.042). The duration of menopause was 2.8±0.6 years. On the scales of physical and psychological components of health in the main groups IA, IIA showed higher values after 3, 6 months of therapy compared to the same parameters in the comparison groups IB, IIB. The dynamics of the decrease in the values of psychoemotional and neurovegetative disorders of the modified menopausal index in the main groups IA, MA after 3 months was more pronounced compared to the same parameters in the comparison groups IB, IIB. The ratio of the chances of normalization of the clinical picture by 6 months for the main group lAand comparison group IB is 2.5 with 95% Cl [1.05-6.16], and for the main group IIAand comparison group IIB — 7.6 with 95% Cl [3.05-19.05]. Conclusion. The inclusion in the treatment of CS and POES along with MGT rTMS improves the quality of life, improves immediate and long-term results.

1. Smetnik VP. Medicine menopause. Moscow: Litera, 2009; 848 p.
2. Yureneva SV. Modern approaches to the correction of menopausal disorders. Moscow: GEOTAR-Media, 2017; 80 p.
3. Manukhin IB. Quality of life and menopause. Moscow: Litterra, 2015; 320 p.
4. Sarrel Р, Portman D, Lefebvre Р, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause 2014; 22(3): 260-6.
5. Gartoulla P, Islam M, Bell R, et al. Prevalence of menopausal symptoms in Australian women at midlife: a systematic review. Climacteric 2014; (17): 529-39.
6. Gartoulla P, Bell R, Worsley R, Davis S. Menopausal vasomotor symptoms are associated with poor self-assessed work ability. Maturitas 2016; (87): 33-9.
7. Alisultanova LS, Bobkova AS, Kochetkov AV, Orekhova EM. Neurotropic magnetotherapy in the treatment of patients with climacteric syndrome. AG-lnfo 2008; (4): 34-7.
8. Aleksandrov VV. Fundamentals of rehabilitation medicine and physiotherapy. Moscow: GEOTAR-Media, 2018; 208 p.
9. Burke М, Fried Р, Pascual-Leone A. Transcranial magnetic stimulation: Neurophysiological and clinical applications. In: MD'Esposito, JH Grafman (Eds). The frontal lobes. Handbook of clinical neurology. Amsterdam: Elsevier, 2019; Vol. 163: p. 73-92. DOI:

2021_03_428-433.pdf285.27 KB

No votes yet